Geranylgeranylacetone protects against small-intestinal injuries induced by diclofenac in patients with rheumatic diseases: A prospective randomized study

Digestive and Liver Disease

Volumn 47, Issue 4, 2015, Pages 280-284

  Xiong, Lishou ^a   Huang, Xinxin ^a   Li, Li ^a   Yang, Xiuyan ^a   Liang, Liuqin ^a   Zhan, Zhongping ^a   Ye, Yujin ^a   Chen, Minhu ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Capsule endoscopy; Geranylgeranylacetone; Intestinal injury; NSAIDs

Indexed keywords

DICLOFENAC; TEPRENONE; ANTIULCER AGENT; DITERPENE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CAPSULE ENDOSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTESTINE INJURY; MALE; PETECHIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHEUMATIC DISEASE; SMALL INTESTINAL INJURY; TREATMENT OUTCOME; CHEMICALLY INDUCED; DRUG EFFECTS; FOLLOW UP; INTESTINAL DISEASES; INTESTINE MUCOSA; PATHOLOGY; RHEUMATIC DISEASES; SMALL INTESTINE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; CAPSULE ENDOSCOPY; DICLOFENAC; DITERPENES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTESTINAL DISEASES; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; PROSPECTIVE STUDIES; RHEUMATIC DISEASES;

EID: 84925301606     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2015.01.005     Document Type: Article

References (23)

1. Xiong L.S., Ma S.Y., Yang X.Y., et al. Clinical survey on gastrointestinal damages induced by nonsteroidal anti-inflammatory drugs. Chinese Journal of Digestive Diseases 2010, 30:222-225.
2. Graham D.Y., Opekun A.R., Willingham F.F., et al. Visible small intestinal mucosal injury in chronic NSAID users. Clinical Gastroenterology and Hepatology 2005, 3:55-59.
3. Goldstein J.L., Eisen G.M., Lewis B., et al. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clinical Gastroenterology and Hepatology 2005, 3:133-141.
4. Higuchi K., Umegaki E., Watanabe T., et al. Present status and strategy of NSAIDs-induced small bowel injury. Journal of Gastroenterology 2009, 44:879-888.
5. Lim Y.J., Chun H.J. Recent advances in NSAIDs-induced enteropathy therapeutics: new options, new challenges. Gastroenterology Research and Practice 2013, 2013:761060.
6. Isomura Y., Yamaji Y., Yamada A., et al. Irsogladine improves small intestinal injuries in regular users of nonsteroidal anti-inflammatory drugs. Gastrointestinal Endoscopy 2014, 80:118-125.
7. Zhang S., Chao G.Q., Lu B. Proton pump inhibitors are not the key for therapying non-steroidal anti-inflammatory drugs-induced small intestinal injury. Rheumatology International 2013, 33:2513-2521.
8. Niwa Y., Nakamura M., Ohmiya N., et al. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. Journal of Gastroenterology 2008, 43:270-276.
9. Asano T., Tanaka K., Yamakawa N., et al. HSP70 confers protection against indomethacin-induced lesions of the small intestine. Journal of Pharmacology and Experimental Therapeutics 2009, 330:458-467.
10. Iwai T., Ichikawa T., Kida M., et al. Protective effect of geranylgeranylacetone against loxoprofen sodium-induced small intestinal lesions in rats. European Journal of Pharmacology 2011, 652:121-125.
11. Niwa Y., Nakamura M., Miyahara R., et al. Geranylgeranylacetone protects against diclofenac-induced gastric and small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, placebo-controlled, double-blinded, cross-over study. Digestion 2009, 80:260-266.
12. Shiotani A., Haruma K., Nishi R., et al. Randomized, double-blind, pilot study of geranylgeranylaceton versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage. Scandinavian Journal of Gastroenterology 2010, 45:292-298.
13. Maiden L., Thjodleifsson B., Seigal A., et al. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clinical Gastroenterology and Hepatology 2007, 5:1040-1045.
14. Gralnek I.M., Defranchis R., Seidman E., et al. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Alimentary Pharmacology and Therapeutics 2008, 27:146-154.
15. Umegaki E., Kuramoto T., Kojima Y., et al. Geranylgeranylacetone, a gastromucoprotective drug, protects against NSAID-induced esophageal, gastroduodenal and small intestinal mucosal injury in healthy subjects: a prospective randomized study involving a comparison with famotidine. Internal Medicine 2014, 53:283-290.
16. Sugimori S., Watanabe T., Tabuchi M., et al. Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs. Digestion 2008, 78:208-213.
17. Wallace J.L., Syer S., Denou E., et al. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology 2011, 141:1314-1322. 1322.e1-5.
18. Satoh H., Amagase K., Takeuchi K. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility. Journal of Pharmacology and Experimental Therapeutics 2012, 343:270-277.
19. Inoue T., Iijima H., Arimitsu J., et al. Amelioration of small bowel injury by switching from nonselective nonsteroidal anti-inflammatory drugs to celecoxib in rheumatoid arthritis patients: a pilot study. Digestion 2014, 89:124-132.
20. Laine L., Maller E.S., Yu C., et al. Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial. Gastroenterology 2004, 127:395-402.
21. Fujimori S., Seo T., Gudis K., et al. Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy. Gastrointestinal Endoscopy 2009, 69:1339-1346.
22. Koulaouzidis A., Douglas S., Plevris J.N. Blue mode does not offer any benefit over white light when calculating Lewis score in small-bowel capsule endoscopy. World Journal of Gastrointestinal Endoscopy 2012, 4:33-37.
23. Yang L., Ge Z.Z., Gao Y.J., et al. Assessment of capsule endoscopy scoring index, clinical disease activity, and C-reactive protein in small bowel Crohn's disease. Journal of Gastroenterology and Hepatology 2013, 28:829-833.